Opioid addiction is treated most effectively with a combination of medication and behavioral therapy. Three FDA-approved medications form the backbone of treatment, and when used long-term, they can reduce the risk of fatal overdose by more than half. Despite outdated stigma around these medications, they remain the single most evidence-backed approach available.
Why Medication Is the First-Line Treatment
Opioid addiction changes the brain’s reward system in ways that willpower and counseling alone rarely overcome. Among people who go through detox without medication, 65% relapse within a month of discharge, and 90% relapse within a year. Those numbers aren’t a reflection of personal failure. They reflect the biology of the disorder.
Medications for opioid use disorder work by interacting with the same receptors in the brain that opioids target. They either partially activate those receptors to prevent withdrawal and cravings, fully activate them in a controlled way, or block them entirely so opioids can’t produce a high. A large study of people receiving medication while incarcerated found that treatment was associated with a 52% lower risk of fatal opioid overdose and a 56% lower risk of death from any cause after release. These aren’t marginal benefits. Medication is the difference between a treatment that works and one that mostly doesn’t.
The Three FDA-Approved Medications
Buprenorphine
Buprenorphine is a partial agonist, meaning it activates the brain’s opioid receptors but only up to a ceiling. Once that ceiling is reached, taking more doesn’t increase the effect. This makes it much harder to misuse than full opioids while still relieving cravings and preventing withdrawal. It comes in several forms: daily dissolving tablets or films placed under the tongue (often combined with naloxone to discourage misuse), and monthly or weekly injections for people who prefer not to take something every day.
Starting buprenorphine requires a specific step. Because of how it binds to receptors, you need to be in moderate withdrawal before taking the first dose. Clinicians measure this using a standardized withdrawal scale, and the score needs to be above a certain threshold. If you take buprenorphine too soon after your last opioid dose, it can actually trigger sudden, intense withdrawal rather than relieve it. This initial hurdle is temporary but important to get right, which is why the first dose is typically guided by a provider.
One significant change in recent years: any doctor with a standard prescribing license can now prescribe buprenorphine. A special federal waiver that used to be required was eliminated in 2023, and there are no longer any caps on how many patients a provider can treat. This has made buprenorphine far more accessible through regular primary care offices, not just specialized addiction clinics.
Methadone
Methadone is a full agonist. It fully activates opioid receptors, which means it relieves cravings and blocks withdrawal completely when dosed correctly. Because it’s a full agonist, it carries more risk of misuse and overdose than buprenorphine, so it’s dispensed through specialized clinics rather than regular pharmacies. Most people start by visiting the clinic daily to receive their dose under supervision. Over time, as stability is demonstrated, take-home doses become available.
Methadone has decades of research behind it and remains the best option for some people, particularly those with severe addiction who haven’t responded well to buprenorphine. The daily clinic visits can feel burdensome, but for many they also provide structure and regular contact with support staff.
Naltrexone
Naltrexone works differently from the other two. It’s an antagonist, meaning it blocks opioid receptors entirely without activating them. If you use opioids while on naltrexone, you won’t feel any effect. The most common form is a monthly injection. The catch is that you need to be fully detoxed from opioids (typically 7 to 14 days) before starting, because blocking the receptors while opioids are still in your system will trigger severe withdrawal. This makes it harder to initiate, and retention rates tend to be lower. But for people who are motivated and have already cleared the detox phase, it’s an effective option that removes the temptation of getting high.
Monthly Injections as an Alternative
Long-acting injectable formulations have become an increasingly popular option. For buprenorphine, monthly injections eliminate the need to take a daily tablet or film. In a 24-week clinical trial, the injectable form performed at least as well as daily sublingual buprenorphine, with a slightly higher rate of opioid-negative urine samples (35% versus 28%). Retention was similar in both groups, with roughly 40% discontinuing by 28 weeks in either case.
The appeal is straightforward: you get one injection and don’t have to think about it for a month. There’s no daily pill to forget, lose, or have stolen. For people with unstable housing or chaotic schedules, this can make the difference between staying in treatment and dropping out.
Behavioral Therapy Alongside Medication
Medication handles the biological side of addiction. Behavioral therapy addresses the patterns, triggers, and often co-occurring mental health conditions that keep the cycle going. The two most studied approaches for opioid addiction are contingency management and cognitive behavioral therapy.
Contingency management uses tangible rewards (often gift cards or vouchers) for meeting treatment goals like negative drug tests. It sounds simple, but the evidence is strong. A meta-analysis covering 74 randomized trials found it meaningfully reduced both opioid use and polysubstance use, and it was the only therapy that significantly improved treatment retention. It works especially well for people who are early in recovery and haven’t yet built internal motivation. The effects are fast and concrete.
Cognitive behavioral therapy takes a different approach. It helps you identify the thought patterns and situations that lead to use, then develop practical strategies to handle them. It acts more slowly than contingency management but produces more durable results over time. CBT is particularly useful when addiction co-occurs with depression, anxiety, or PTSD, because the same skills apply to both conditions. Sessions typically involve recognizing cycles of behavior, practicing problem-solving, and building coping strategies through role-play and structured exercises.
Most treatment programs combine elements of both, sometimes adding motivational interviewing early on to help people who are still ambivalent about change.
How Long Treatment Lasts
There’s no fixed timeline. The relapse data makes the case for long-term medication: with 90% of detox-only patients relapsing within a year, stopping medication prematurely is one of the biggest risk factors for returning to use. Many addiction specialists recommend staying on medication indefinitely, similar to how someone with high blood pressure stays on their medication even when their numbers look good.
Some people do eventually taper off medication successfully, but this works best when it’s done very gradually, under medical supervision, and after a long period of stability. Tapering too quickly or too early is a common reason for relapse. The decision to taper should be made collaboratively with a provider, not driven by pressure from others or a sense that medication is a crutch.
Harm Reduction for People Not Yet in Treatment
Not everyone with opioid addiction is ready for or able to access formal treatment right away. Harm reduction strategies help keep people alive in the meantime. Naloxone, the overdose-reversal medication, is now widely available without a prescription. Having a naloxone kit nearby is one of the most effective ways to prevent overdose death, and many distribution programs also provide training on how to use it.
Fentanyl test strips allow people to check whether their drugs contain fentanyl before using. In studies of young adults who used the strips, those who received a positive result were significantly more likely to adopt risk-reduction behaviors like using smaller amounts or making sure someone else was present. Pairing test strip distribution with naloxone training creates a practical safety net that reduces overdose risk even outside of formal treatment settings.